Summary

The global Microneedles for Trans & Intradermal Drug Delivery market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Microneedles for Trans & Intradermal Drug Delivery is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Microneedles for Trans & Intradermal Drug Delivery is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Microneedles for Trans & Intradermal Drug Delivery is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Microneedles for Trans & Intradermal Drug Delivery players cover Becton Dickinson, Nanopass Technologies, Radius Health, Clearside Biomedical, Dr. Prausnitz Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Microneedles for Trans & Intradermal Drug Delivery Industry Forecast” looks at past sales and reviews total world Microneedles for Trans & Intradermal Drug Delivery sales in 2024, providing a comprehensive analysis by region and market sector of projected Microneedles for Trans & Intradermal Drug Delivery sales for 2025 through 2031. With Microneedles for Trans & Intradermal Drug Delivery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Microneedles for Trans & Intradermal Drug Delivery industry.
This Insight Report provides a comprehensive analysis of the global Microneedles for Trans & Intradermal Drug Delivery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Microneedles for Trans & Intradermal Drug Delivery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Microneedles for Trans & Intradermal Drug Delivery market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microneedles for Trans & Intradermal Drug Delivery and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microneedles for Trans & Intradermal Drug Delivery.
This report presents a comprehensive overview, market shares, and growth opportunities of Microneedles for Trans & Intradermal Drug Delivery market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Solid Microneedles
Hollow Microneedles
Dissolvable Microneedles
Segmentation by Application:
Drugs
Vaccines
Proteins
Peptides
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Becton Dickinson
Nanopass Technologies
Radius Health
Clearside Biomedical
Dr. Prausnitz Group
Zosano Pharma
Corium International
Circassia
Valeritas, Inc.
BD Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Microneedles for Trans & Intradermal Drug Delivery market?
What factors are driving Microneedles for Trans & Intradermal Drug Delivery market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Microneedles for Trans & Intradermal Drug Delivery market opportunities vary by end market size?
How does Microneedles for Trans & Intradermal Drug Delivery break out by Type, by Application?

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Microneedles for Trans & Intradermal Drug Delivery Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Microneedles for Trans & Intradermal Drug Delivery by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Microneedles for Trans & Intradermal Drug Delivery by Country/Region, 2020, 2024 & 2031
2.2 Microneedles for Trans & Intradermal Drug Delivery Segment by Type
2.2.1 Solid Microneedles
2.2.2 Hollow Microneedles
2.2.3 Dissolvable Microneedles
2.3 Microneedles for Trans & Intradermal Drug Delivery Sales by Type
2.3.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2020-2025)
2.3.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue and Market Share by Type (2020-2025)
2.3.3 Global Microneedles for Trans & Intradermal Drug Delivery Sale Price by Type (2020-2025)
2.4 Microneedles for Trans & Intradermal Drug Delivery Segment by Application
2.4.1 Drugs
2.4.2 Vaccines
2.4.3 Proteins
2.4.4 Peptides
2.4.5 Others
2.5 Microneedles for Trans & Intradermal Drug Delivery Sales by Application
2.5.1 Global Microneedles for Trans & Intradermal Drug Delivery Sale Market Share by Application (2020-2025)
2.5.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue and Market Share by Application (2020-2025)
2.5.3 Global Microneedles for Trans & Intradermal Drug Delivery Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Microneedles for Trans & Intradermal Drug Delivery Breakdown Data by Company
3.1.1 Global Microneedles for Trans & Intradermal Drug Delivery Annual Sales by Company (2020-2025)
3.1.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Company (2020-2025)
3.2 Global Microneedles for Trans & Intradermal Drug Delivery Annual Revenue by Company (2020-2025)
3.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Company (2020-2025)
3.2.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Company (2020-2025)
3.3 Global Microneedles for Trans & Intradermal Drug Delivery Sale Price by Company
3.4 Key Manufacturers Microneedles for Trans & Intradermal Drug Delivery Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Microneedles for Trans & Intradermal Drug Delivery Product Location Distribution
3.4.2 Players Microneedles for Trans & Intradermal Drug Delivery Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Microneedles for Trans & Intradermal Drug Delivery by Geographic Region
4.1 World Historic Microneedles for Trans & Intradermal Drug Delivery Market Size by Geographic Region (2020-2025)
4.1.1 Global Microneedles for Trans & Intradermal Drug Delivery Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Microneedles for Trans & Intradermal Drug Delivery Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Microneedles for Trans & Intradermal Drug Delivery Market Size by Country/Region (2020-2025)
4.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Annual Sales by Country/Region (2020-2025)
4.2.2 Global Microneedles for Trans & Intradermal Drug Delivery Annual Revenue by Country/Region (2020-2025)
4.3 Americas Microneedles for Trans & Intradermal Drug Delivery Sales Growth
4.4 APAC Microneedles for Trans & Intradermal Drug Delivery Sales Growth
4.5 Europe Microneedles for Trans & Intradermal Drug Delivery Sales Growth
4.6 Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales Growth
5 Americas
5.1 Americas Microneedles for Trans & Intradermal Drug Delivery Sales by Country
5.1.1 Americas Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2020-2025)
5.1.2 Americas Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2020-2025)
5.2 Americas Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2020-2025)
5.3 Americas Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Microneedles for Trans & Intradermal Drug Delivery Sales by Region
6.1.1 APAC Microneedles for Trans & Intradermal Drug Delivery Sales by Region (2020-2025)
6.1.2 APAC Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2020-2025)
6.2 APAC Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2020-2025)
6.3 APAC Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Microneedles for Trans & Intradermal Drug Delivery by Country
7.1.1 Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2020-2025)
7.1.2 Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2020-2025)
7.2 Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2020-2025)
7.3 Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery by Country
8.1.1 Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2020-2025)
8.1.2 Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2020-2025)
8.2 Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2020-2025)
8.3 Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Microneedles for Trans & Intradermal Drug Delivery
10.3 Manufacturing Process Analysis of Microneedles for Trans & Intradermal Drug Delivery
10.4 Industry Chain Structure of Microneedles for Trans & Intradermal Drug Delivery
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Microneedles for Trans & Intradermal Drug Delivery Distributors
11.3 Microneedles for Trans & Intradermal Drug Delivery Customer
12 World Forecast Review for Microneedles for Trans & Intradermal Drug Delivery by Geographic Region
12.1 Global Microneedles for Trans & Intradermal Drug Delivery Market Size Forecast by Region
12.1.1 Global Microneedles for Trans & Intradermal Drug Delivery Forecast by Region (2026-2031)
12.1.2 Global Microneedles for Trans & Intradermal Drug Delivery Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Microneedles for Trans & Intradermal Drug Delivery Forecast by Type (2026-2031)
12.7 Global Microneedles for Trans & Intradermal Drug Delivery Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Becton Dickinson
13.1.1 Becton Dickinson Company Information
13.1.2 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Product Portfolios and Specifications
13.1.3 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Becton Dickinson Main Business Overview
13.1.5 Becton Dickinson Latest Developments
13.2 Nanopass Technologies
13.2.1 Nanopass Technologies Company Information
13.2.2 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Product Portfolios and Specifications
13.2.3 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Nanopass Technologies Main Business Overview
13.2.5 Nanopass Technologies Latest Developments
13.3 Radius Health
13.3.1 Radius Health Company Information
13.3.2 Radius Health Microneedles for Trans & Intradermal Drug Delivery Product Portfolios and Specifications
13.3.3 Radius Health Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Radius Health Main Business Overview
13.3.5 Radius Health Latest Developments
13.4 Clearside Biomedical
13.4.1 Clearside Biomedical Company Information
13.4.2 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Product Portfolios and Specifications
13.4.3 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Clearside Biomedical Main Business Overview
13.4.5 Clearside Biomedical Latest Developments
13.5 Dr. Prausnitz Group
13.5.1 Dr. Prausnitz Group Company Information
13.5.2 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Product Portfolios and Specifications
13.5.3 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Dr. Prausnitz Group Main Business Overview
13.5.5 Dr. Prausnitz Group Latest Developments
13.6 Zosano Pharma
13.6.1 Zosano Pharma Company Information
13.6.2 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Product Portfolios and Specifications
13.6.3 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Zosano Pharma Main Business Overview
13.6.5 Zosano Pharma Latest Developments
13.7 Corium International
13.7.1 Corium International Company Information
13.7.2 Corium International Microneedles for Trans & Intradermal Drug Delivery Product Portfolios and Specifications
13.7.3 Corium International Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Corium International Main Business Overview
13.7.5 Corium International Latest Developments
13.8 Circassia
13.8.1 Circassia Company Information
13.8.2 Circassia Microneedles for Trans & Intradermal Drug Delivery Product Portfolios and Specifications
13.8.3 Circassia Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Circassia Main Business Overview
13.8.5 Circassia Latest Developments
13.9 Valeritas, Inc.
13.9.1 Valeritas, Inc. Company Information
13.9.2 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Product Portfolios and Specifications
13.9.3 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Valeritas, Inc. Main Business Overview
13.9.5 Valeritas, Inc. Latest Developments
13.10 BD Medical
13.10.1 BD Medical Company Information
13.10.2 BD Medical Microneedles for Trans & Intradermal Drug Delivery Product Portfolios and Specifications
13.10.3 BD Medical Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 BD Medical Main Business Overview
13.10.5 BD Medical Latest Developments
14 Research Findings and Conclusion